Approval · Notice of Compliance 25293 · 2021
CHLORHEXIDINE: Notice of Compliance 25293
Issued February 25, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25293
- Date
- February 25, 2021
- Company
- Bajaj Medical, LlcChicago, Illinois, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Change in product ownership
- Canadian reference product
- PERIDEX ORAL RINSE (Procter & Gamble Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CHLORHEXIDINE | 02242329 | Cancelled (Unreturned Annual) |
Medicinal ingredients
- CHLORHEXIDINE GLUCONATE 0.12 PER